Magnamosis First-in-human Study of Feasibility and Safety

NACompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

May 1, 2014

Primary Completion Date

November 30, 2017

Study Completion Date

November 30, 2017

Conditions
Intestinal Anastomosis Complication
Interventions
DEVICE

Magnamosis

Single-use, sterile device enables creation of a circular compression intestinal anastomosis. Device is comprised of matched pair of self-centering rare earth magnets encased in medical grade polycarbonate. Geometry of magnets' mating surfaces applies force on inside of mated rings to produce compression necrosis of intervening intestinal walls. Lesser force on outside of mated rings produces inflammatory healing of the two co-apted intestinal walls. Internal lumen creates patency of the anastomosis to prevent intestinal obstruction during compression anastomosis creation. In 5-10 days, mated rings with necrotic tissue falls into intestinal lumen and is naturally expelled with stool, leaving a well-healed anastomosis.

Trial Locations (2)

94143

University of California, San Francisco - Parnassus Campus, San Francisco

94158

UCSF-Mission Bay, San Francisco

All Listed Sponsors
collaborator

University of California, San Francisco

OTHER

lead

Michael Harrison

OTHER

NCT02043392 - Magnamosis First-in-human Study of Feasibility and Safety | Biotech Hunter | Biotech Hunter